Relationship Between Brucella Immunocomplex and Glomerulonephritis
World Small Animal Veterinary Association World Congress Proceedings, 2007
Ebtehaj Pishva

Abstract

Background

Brucellosis is a zoonotic disease with a very wide spectrum of clinical findings. Brucellosis is about 10 times higher in patients with kidney failure (dialysis) compared to population background. Precipitation of immunocomplexes produced by Brucellosis is important in glomerulonephritis. Because the hallmark of glomerular diseases is abnormal protein loss in the urine we have decided to study proteinuria in Brucellosis immunocomplex. The aim of this study was to evaluate probable relationship between brucellosis and glomerulonephritis.

Methods

This is a cross sectional study, performed on 200 patients with a history of the disease for about 1 year, were diagnosed as having chronic brucellosis through those tests Brucella serum agglutination test (SAT) and SAT with 2-mercaptoethanol.The diagnosis was confirmed in 150 patients and by applying Brucella Standard Agglutination Test (SAT) and 2-mercaptoethanol test (2-ME) titers of IgG/IgM and IgG/IgA in two groups of "with proteinuria" and "without proteinuria" was measured.

Results

Both SAT and 2-ME tests test demonstrated that proteinuria increases with rising antibodies titers. In SAT, titer 1/160 was the most frequent, observed in 44% of the patients. In 2-ME test titer 1/40 was observed in 44% of the patients and was the most frequent titer.

Conclusion

Our results clearly demonstrated that in both chronic and acute patients proteinuria increases with raising IgG/IgA and IgM/IgG titers, and therefore can cause nephropathy but chronic Brucellosis or untreated brucellosis is more important because it can permanently damage kidney.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Ebtehaj Pishva
Medical Sciences University
Iran


MAIN : Nephrology : Brucella Immunocomplex
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27